1. Ma, Shuoshuo, Ma, Yang, Qi, Feiyu, Lu, Zheng, Zhang, Dengyong. 2023. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis. In World journal of surgical oncology, 21, 293. doi:10.1186/s12957-023-03176-6. https://pubmed.ncbi.nlm.nih.gov/37718459/
2. Zeng, Jing, Ma, Xiao, Wang, Jinjing, Li, Zhiyuan, Fang, Yi. 2019. Down-regulated HSDL2 expression suppresses cell proliferation and promotes apoptosis in papillary thyroid carcinoma. In Bioscience reports, 39, . doi:10.1042/BSR20190425. https://pubmed.ncbi.nlm.nih.gov/31101684/
3. Shi, Yujia, Mao, Zhengdao, Huang, Yanhua, Huang, Jianan, Zhang, Qian. . Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression. In Bioscience reports, 40, . doi:10.1042/BSR20200348. https://pubmed.ncbi.nlm.nih.gov/32211805/
4. Li, Yingpeng, Zhao, Huan, Pang, Min, Yang, Dazuo, Zhou, Yibing. 2022. Expression Profile of Hydroxysteroid Dehydrogenase-like 2 in Polychaete Perinereis aibuhitensis in Response to BPA. In Life (Basel, Switzerland), 13, . doi:10.3390/life13010010. https://pubmed.ncbi.nlm.nih.gov/36675957/
5. Jia, Ling-Hua, Hu, Mei-Di, Liu, Yuan, Wang, Jin-Gen, Li, Qiu-Gen. 2019. HSDL2 Promotes Bladder Cancer Growth In Vitro and In Vivo. In International journal of medical sciences, 16, 654-659. doi:10.7150/ijms.31288. https://pubmed.ncbi.nlm.nih.gov/31217732/
6. Dong, Bing, Yang, Yang, Han, Anna, Wang, Yixuan, Piao, Junjie. 2019. Ectopic expression of HSDL2 is related to cell proliferation and prognosis in breast cancer. In Cancer management and research, 11, 6531-6542. doi:10.2147/CMAR.S205316. https://pubmed.ncbi.nlm.nih.gov/31372054/